Browsing by Author "Artac M."
Now showing items 1-1 of 1
-
Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study
Uncu D.; Bayoglu I.V.; Arslan U.Y.; Kucukoner M.; Artac M.; Koca D.; Oguz A. (Asian Pacific Organization for Cancer Prevention, 2015)Background: For HER2 positive metastatic breast cancer (MBC), continuing anti-HER2 therapy beyond progression is associated with improved outcome. However retreatment with trastuzumab after lapatinib progression is ...